Dr. Scott Gottlieb served as the twenty-third commissioner of the US Food and Drug Administration and is a resident fellow at the American Enterprise Institute. He is a regular contributor to the business news channel CNBC and a partner at the venture capital firm New Enterprise Associates. Dr. Gottlieb serves on the board of directors of the pharmaceutical company Pfizer Inc. and the genomic sequencing company Illumina, Inc. Fortune magazine has recognized him as one of the “World’s 50 Greatest Leaders,” and Time magazine has named him one of its “50 People Transforming Healthcare.” A graduate of Wesleyan University and the Mount Sinai School of Medicine, Dr. Gottlieb is an elected member of the National Academy of Medicine. He lives with his family in Westport, Connecticut.